{"title":"Sharpa vs Xynova: Manipulation compared","url":"https://www.frontiertechintelligence.com/compare/sharpa-vs-xynova","comparison":"Sharpa ranks 11 on the Humanoids 100 with a score of 84; Xynova ranks 30 with 72. Sharpa is ahead on deployment, production, commercials, technology and leverage. Xynova is ahead on firepower. Level on progress and positioning. Sharpa is based in Singapore, Singapore, Xynova in Hangzhou, China. Sharpa: private. Xynova: private. Sharpa is named in 85 signals and Xynova in 2.","companies":[{"name":"Sharpa","url":"https://www.frontiertechintelligence.com/companies/sharpa","city":"Singapore","country":"Singapore","stage":"private","founded":null,"last_round":null,"positioning":"Sharpa (Singapore HQ, Shanghai manufacturing) is a self-described unicorn (founded 2024) making the SharpaWave dexterous hand (22 active DoF, >1,000 tactile pixels per fingertip, ~$50,000 per hand) in mass production since October 2025, plus the North full-body robot shown at CES 2026. Its reference-design win is decisive: NVIDIA's Isaac GR00T Reference Humanoid (Computex 2026) is built on a Unitree H2 chassis with Sharpa Wave hands, the first dexterous reference design on the GR00T platform, with lab partners including NVIDIA, Google, MIT, and Stanford. Revenue is estimated at 10-100m (early orders from global technology firms).","assessed_in":{"domain":"Humanoids","list":"Humanoids 100","rank":11,"score":84,"tier":"member","scores":{"leverage":10,"position":8,"progress":10,"firepower":7,"commercial":6,"deployment":7,"production":8,"technology":10},"why":"Sharpa sells North, a general-purpose humanoid robot, to enterprise operators for autonomous service and dexterous manipulation.","segment":"Manipulation","layer":"Components"},"signals_total":85,"facts_total":78},{"name":"Xynova","url":"https://www.frontiertechintelligence.com/companies/xynova","city":"Hangzhou","country":"China","stage":"private","founded":null,"last_round":null,"positioning":"Xynova (Hangzhou) is a Chinese maker of tendon-driven dexterous hands (the Flex 1 at 25 DoF, 380g, >30kg lift, claimed the lightest and highest-load high-DoF hand on the market, plus the Flex2), built full-stack in-house down to motors, reducers, and ball screws. It raised ~RMB 1B (~$148M) within 18 months of its end-2024 founding, with CATL Capital, Xiaomi, and Li Auto simultaneously on its cap table, the fastest capital accumulation in the hands segment after LinkerBot. It leads the high-performance weight-to-load contest on published specifications; revenue is undisclosed.","assessed_in":{"domain":"Humanoids","list":"Humanoids 100","rank":30,"score":72,"tier":"member","scores":{"leverage":8,"position":8,"progress":10,"firepower":8,"commercial":4,"deployment":4,"production":6,"technology":8},"why":"Xynova sells the Flex 2 bionic dexterous hand to humanoid and robotics manufacturers for advanced robotic manipulation.","segment":"Manipulation","layer":"Components"},"signals_total":2,"facts_total":20}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}